Research and Clinical Trials
About Us
As part of our mission to provide comprehensive and state-of-the-art care, all IUI providers participate in clinical trials. Our research team works with some of the world’s leading pharmaceutical and medical technology companies in many phases of drug and device research. Research at IUI is conducted according to Good Clinical Practice (GCP) and in compliance with all federal regulations. Our team maintains membership and certifications through the Association of Clinical Research Professionals (ACRP).
About Clinical Trials
Every new drug and device must go through an extensive process to achieve Food and Drug Administration (FDA) approval. Phase I trials investigate the safety of a drug in a small number of healthy volunteers. In Phase II trials, the drug is tested in a small number of patients that have the diagnosis the medication is designed to treat. Phase II research helps determine a tolerable, safe and effective dose of the drug. Phase III trials involve larger numbers of patients with the condition/disease and are to further prove safety and efficacy. Phase IV trials occur post FDA approval for a variety of reasons, including the addition of an indication or head-to-head comparisons.
Benefits of Participation
Advantages of participation in a clinical trial include:
- Access to the latest treatment before it is widely available
- Compensation for your time and travel related to your research appointments
- Close monitoring of your medical condition
- Advancement of medical therapy for patients like yourself
Drawbacks of participation in a clinical trial include:
- Treatment may not benefit your condition
- May require more frequent visits to the clinic
- Unanticipated or undesired side effects from the investigational product
Becoming a Participant
The Research Team will provide you with the informed consent form (ICF) packet for your review. The ICF provides all the details of the study, including the drug or device, risks and benefits, compensation, tests, procedures, etc. If you choose to participate, you will then be screened for the study. At this visit the Research staff and the principal investigator will conduct procedures as mandated by the study protocol. If you qualify, you will continue with study visits. You may withdraw from participation at any time.
Contact Us
If you are interested in learning more about Research or a particular study, please contact us via email at research@idurology.com or call 208-639-4938.
Our Staff
Joseph H. Williams, MD, CPI

Karrie Fox, BS
Email: karried@idurology.com, Contact: (208) 639 4884

Brian Mihm, LPN
Email: bmihm@idurology.com, Contact: (208) 639-4938
